Interest Expense On Debt Изменить Дата
Alnylam Pharmaceuticals USD 31.34M 445K 2023-12
Arrowhead Research USD 5.37M 105K 2023-12
BioCryst Pharmaceuticals USD 27.34M 1.57M 2023-09
BioMarin Pharmaceutical USD 6.1M 2.32M 2023-12
Celltrion KRW 3.45B 1.42B 2023-12
Deva Holding AS TRY 272.53M 69.04M 2023-09
Ecofibre AUD 1.61M 291K 2023-06
Esperion Therapeutics USD 15M 458K 2023-09
Halozyme Therapeutics USD 5.22M 715K 2023-12
Ionis Pharmaceuticals USD 4.56M 355K 2023-12
Kangmei Pharma CNY 3.12M 140.6K 2023-09
Knight Therapeutics CAD 2.6M 401K 2023-09
Moderna USD 6M 4M 2023-12
Nektar Therapeutics USD 5.91M 242K 2023-09
Neurocrine Biosciences USD 1.1M 200K 2023-09
Omeros USD 7.92M 16K 2023-09
OPKO Health USD 3.45M 69K 2023-12
Organigram Holdings CAD 45K 56K 2022-06
Ovoca Bio EUR 7K 6K 2022-06
Pfizer USD 689M 6M 2023-12
Probiotec AUD 2.85M 76.68K 2023-06
PTC Therapeutics USD 44.28M 16.11M 2023-12
Qiagen NV USD 13.02M 479K 2023-09
Regeneron Pharmaceuticals USD 18.3M 500K 2023-12
Roche Holding CHF 401M 53M 2023-06
Sarepta Therapeutics USD 5.23M 5K 2023-09
Sino Biopharmaceutical CNY 304.14M 31.41M 2023-06
Vertex Pharmaceuticals USD 10.9M 300K 2023-09
Zz Pientze Pharmaceu 9.55M 1.59M 2023-09



Ionis Pharmaceuticals Процентные Расходы - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2024.